Sensipar and Appetite - decreased - a phase IV clinical study of FDA data

Summary:

Appetite - decreased is reported as a side effect among people who take Sensipar (cinacalcet hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Renagel, and have Hyperparathyroidism.

The phase IV clinical study analyzes which people have Appetite - decreased when taking Sensipar. It is created by eHealthMe based on reports of 45,992 people who have side effects when taking Sensipar from the FDA, and is updated regularly.

What is Sensipar?

Sensipar has active ingredients of cinacalcet hydrochloride. It is often used in hyperparathyroidism secondary. eHealthMe is studying from 46,034 Sensipar users. Check the latest studies of Sensipar.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,598 drugs and 4,588 conditions by eHealthMe. Check the latest studies of Appetite - decreased.

On Jul, 07, 2026

45,992 people reported to have side effects when taking Sensipar.
Among them, 834 people (1.81%) have Appetite - decreased.

Could Sensipar cause Appetite - decreased?

Among these 834 people:

How long have people been on Sensipar when they have Appetite - decreased? *

Click here to view more results

What is the gender of people who have Appetite - decreased when taking Sensipar? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Sensipar and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sensipar:

Sensipar (46,034 reports)

Appetite - decreased treatments and more:

Appetite - decreased (264,653 reports)

How severe was Appetite - decreased and when was it recovered:

Appetite - decreased in Sensipar

Expand to all the drugs that have ingredients of cinacalcet hydrochloride:

Appetite - decreased and drugs with ingredients of cinacalcet hydrochloride (994 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sensipar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - decreased:

Appetite - decreased (3,598 drugs)

Browse all the conditions that are associated with Appetite - decreased:

Appetite - decreased (4,588 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cinacalcet hydrochloride (the active ingredients of Sensipar) and Sensipar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.